Protective Effect of Ulinastatin Against Negative Inflammatory Response and Organ Dysfunction After Acute Type a Aortic Dissection Surgery (PANDA I)

NCT04711889 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

203

Enrollment

OTHER

Sponsor class

Conditions

Acute Aortic Syndrome
Type a Aortic Dissection

Interventions

DRUG: Ulinastatin
DRUG: Blank control

Sponsor

Nanjing Medical University

Collaborators

[object Object]